A
Ayman Koteish
Researcher at Johns Hopkins University
Publications - 32
Citations - 3179
Ayman Koteish is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Fatty liver & Liver disease. The author has an hindex of 19, co-authored 29 publications receiving 2847 citations. Previous affiliations of Ayman Koteish include Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994
Mariana Lazo,Ruben Hernaez,Ruben Hernaez,Mark S. Eberhardt,Susanne Bonekamp,Ihab R. Kamel,Eliseo Guallar,Ayman Koteish,Frederick L. Brancati,Jeanne M. Clark +9 more
TL;DR: The results extend previous national estimates of the prevalence of NAFLD in the US population and highlight the burden of this disease, which is more common in men, Mexican Americans, and people with diabetes and obesity are the most affected groups.
Journal ArticleDOI
Animal models of steatosis.
Ayman Koteish,Anna Mae Diehl +1 more
TL;DR: Animals with genetic or environmental induction of hepatic lipogenesis appear to be useful models for human nonalcoholic fatty liver disease in which hyperinsulinemia and defective leptin signaling are conspicuous at early stages of the disease process.
Journal ArticleDOI
Transforming Growth Factor-β1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro
TL;DR: It is shown that TGF-β1 induces an epithelial-to-mesenchymal transition (EMT) state in mature hepatocytes in vitro, and a potentially crucial role for EMT in the development and progression of hepatic fibrogenesis is supported.
Journal ArticleDOI
Impaired liver regeneration in inducible nitric oxide synthasedeficient mice
Rudra Rai,Fung Yee J. Lee,Anthony Rosen,Shiqi Yang,Hui Zhi Lin,Ayman Koteish,Foo Y. Liew,Carlos Zaragoza,Charles J. Lowenstein,Anna Mae Diehl +9 more
TL;DR: It is reported that the hepatocyte proliferative response to partial liver resection is severely inhibited in transgenic mice with targeted disruption of the iNOS gene, suggesting that during successful tissue regeneration, injury-related cytokines induce factors, such as iN OS and its product, NO, that protect surviving cells from cytokine-mediated death.
Journal ArticleDOI
Meta‐analysis: vitamin D and non‐alcoholic fatty liver disease
M. Eliades,E. Spyrou,N. Agrawal,Mariana Lazo,Frederick L. Brancati,James J. Potter,Ayman Koteish,Jeanne M. Clark,Eliseo Guallar,Ruben Hernaez +9 more
TL;DR: Non‐alcoholic fatty liver disease (NAFLD) is a highly prevalent condition and emerging evidence suggests that vitamin D may play a role in the pathogenesis of NAFLD.